Who can develop ONJ?
The FDA recognizes additional risk factors associated with the development of osteonecrosis (not limited to the jaw) in cancer patients, such as female sex, advanced age, edentulous regions, combination cancer therapy, blood dyscrasias/metastatic disease, anemia coagulopathy, surgical dental procedures, and prior infection. While on treatment, patients taking IV bisphosphonates should avoid invasive dental procedures if possible. For patients who develop ONJ while on bisphosphonate therapy, dental surgery may exacerbate the condition. For patients requiring dental procedures, there are no data available to suggest whether discontinuation of bisphosphonate treatment reduces the risk of ONJ. Clinical judgment of the treating physician should guide the management plan of each patient based on individual benefit/risk assessment.
Related Questions
- What do you think the US needs to continue to grow the sport, and more importantly even, to let it develop its own character rather than being the poor cousin of Euro racing?
- How can I develop some concrete way to let the child know that he has completed a particular activity rather than my just signing FINISHED?
- How Do You Develop A Strong High Singing Voice?
